You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

OXSORALEN-ULTRA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oxsoralen-ultra, and when can generic versions of Oxsoralen-ultra launch?

Oxsoralen-ultra is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in OXSORALEN-ULTRA is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oxsoralen-ultra

A generic version of OXSORALEN-ULTRA was approved as methoxsalen by STRIDES PHARMA on June 5th, 2014.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OXSORALEN-ULTRA?
  • What are the global sales for OXSORALEN-ULTRA?
  • What is Average Wholesale Price for OXSORALEN-ULTRA?
Summary for OXSORALEN-ULTRA
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 1
Clinical Trials: 1
What excipients (inactive ingredients) are in OXSORALEN-ULTRA?OXSORALEN-ULTRA excipients list
DailyMed Link:OXSORALEN-ULTRA at DailyMed
Drug patent expirations by year for OXSORALEN-ULTRA
Recent Clinical Trials for OXSORALEN-ULTRA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
M.D. Anderson Cancer CenterPhase 1

See all OXSORALEN-ULTRA clinical trials

US Patents and Regulatory Information for OXSORALEN-ULTRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch OXSORALEN-ULTRA methoxsalen CAPSULE;ORAL 019600-001 Oct 30, 1986 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.